← Open Payments lookup

COLLETTE ODIBO: Open Payments

NPI 1255661294 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,242 in 57 payments from 10 companies in 2025. Trend: 2023 $604 · 2024 $1,098 · 2025 $1,242

Food & beverage: $1,242
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$244
Vanda Pharmaceuticals Inc.7$212
ABBVIE INC.10$181
E.R. Squibb & Sons, L.L.C.7$170
Lundbeck LLC6$132
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$89
Alkermes, Inc.3$74
Neurocrine BioSciences, Inc.3$62
Janssen Pharmaceuticals, Inc1$42
HARMONY BIOSCIENCES LLC1$36

Products named: ABILIFY ASIMTUFII, REXULTI, VRAYLAR, COBENFY, FANAPT, CAPLYTA, HETLIOZ, INGREZZA.

Industry payments across DC — which companies pay providers there.